Correlation Between Scandinavian ChemoTech and Vicore Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scandinavian ChemoTech and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scandinavian ChemoTech and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scandinavian ChemoTech AB and Vicore Pharma Holding, you can compare the effects of market volatilities on Scandinavian ChemoTech and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scandinavian ChemoTech with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scandinavian ChemoTech and Vicore Pharma.

Diversification Opportunities for Scandinavian ChemoTech and Vicore Pharma

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Scandinavian and Vicore is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Scandinavian ChemoTech AB and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and Scandinavian ChemoTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scandinavian ChemoTech AB are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of Scandinavian ChemoTech i.e., Scandinavian ChemoTech and Vicore Pharma go up and down completely randomly.

Pair Corralation between Scandinavian ChemoTech and Vicore Pharma

Assuming the 90 days trading horizon Scandinavian ChemoTech AB is expected to under-perform the Vicore Pharma. In addition to that, Scandinavian ChemoTech is 1.12 times more volatile than Vicore Pharma Holding. It trades about -0.1 of its total potential returns per unit of risk. Vicore Pharma Holding is currently generating about -0.02 per unit of volatility. If you would invest  795.00  in Vicore Pharma Holding on September 3, 2024 and sell it today you would lose (11.00) from holding Vicore Pharma Holding or give up 1.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Scandinavian ChemoTech AB  vs.  Vicore Pharma Holding

 Performance 
       Timeline  
Scandinavian ChemoTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scandinavian ChemoTech AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Scandinavian ChemoTech is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Vicore Pharma Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vicore Pharma Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Scandinavian ChemoTech and Vicore Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scandinavian ChemoTech and Vicore Pharma

The main advantage of trading using opposite Scandinavian ChemoTech and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scandinavian ChemoTech position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.
The idea behind Scandinavian ChemoTech AB and Vicore Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital